Drug Safety

Prevention and Pharmacovigilance: What Should We Do, What Can We Do?
pp. 87-90(4)
Author: Edwards, I. Ralph

Risk Evaluation and Mitigation Strategies (REMS): Educating the Prescriber
pp. 91-104(14)
Authors: Nicholson, Susan C.; Peterson, Janet; Yektashenas, Behin

Methods for Assessing the Preventability of Adverse Drug Events: A Systematic Review
pp. 105-126(22)
Authors: >Katja Marja Hakkarainen,; >Karolina Andersson Sundell,; Petzold, Max; Hägg, Staffan

Effects of Proton Pump Inhibitors on Platelet Function in Patients Receiving Clopidogrel: A Systematic Review
pp. 127-139(13)
Authors: >Chun Shing Kwok,; >Yoon Kong Loke,

Selected National Pharmacovigilance Websites: An Analysis of Contents
pp. 141-148(8)
Authors: Barker, Charlotte I.S.; Talbot, John C.C.; Aronson, Jeffrey K.

Trends in Hepatic Injury Associated with Unintentional Overdose of Paracetamol (Acetaminophen) in Products with and without Opioid: An Analysis Using the National Poison Data System of the American Association of Poison Control Centers, 2000-7
pp. 149-157(9)
Authors: Bond, G. Randall; Ho, Mona; Woodward, Randall W.

Erratum
pp. 158-158(1)

Risk of Cardiac Valve Regurgitation with Dopamine Agonist use in Parkinson's Disease and Hyperprolactinaemia: A Multi-Country, Nested Case-Control Study
pp. 159-171(13)
Authors: Trifirò, Gianluca; Mokhles, M. Mostafa; Dieleman, Jeanne P.; van Soest, Eva M.; Verhamme, Katia; Mazzaglia, Giampiero; Herings, Ron; >Cynthia de Luise,; Ross, Douglas; Brusselle, Guy; Colao, Annamaria; Haverkamp, Wilhelm; Schade, Rene; >Guy van Camp,; Zanettini, Renzo; Sturkenboom, Miriam C.